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Summary Local immunoregulation mediated by mononuclear tumour-infiltrating cells is considered of importance for tumour progression of
colorectal cancer, although the balance between immunosuppressor and cytotoxic activities is unclear. Colorectal cancers from 26 patients
were investigated using a panel of monoclonal antibodies in order to identify subsets of mononuclear inflammatory cells and to study their
pattern of distribution in relation to tumour stage and cytotoxic immune reactivity against the tumour. In all but five tumours, mononuclear
cells, lymphocytes or monocytes were present in fairly large numbers, particularly in the stroma. The infiltration of CD4+ mononuclear cells
predominated over the CD8+ subset. Infiltration near the tumour cells was found in four cancers only. Stromal infiltration of CD11c+
macrophages was found in all but eight tumours. Small regressive areas, in which the histological architecture of the tumours was broken
down, were found in 17 tumours with intense or moderate infiltration by CD4+ lymphocytes or CD11c+ macrophages. Probably this destruction
of tumour tissue was caused by cytotoxic activity of the tumour-infiltrating mononuclear cells. In Dukes' class A and B tumours, CD4+
lymphocytes predominated over CD4+ cells with macrophage morphology, but the latter were increasingly found in Dukes' class C and D
disease. The occurrence of MHC Il-positive macrophages and lymphocytes in different Dukes' classes was similar to that of CD4+ cells. In
contrast to this, CD11c+ and CD11a+ cells were more frequent in Dukes' A and B class tumours compared with Dukes' C and D. Four out of
nine tumours of the latter stages showed a poor inflammatory reaction. The interpretation of our results is that the subsets of tumour-
infiltrating mononuclear cells change with advancing Dukes' class and that the local immune control is gradually broken down in progressive
tumour growth, even if some cytotoxic activity is still present.
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Immune reactivity to colorectal cancer has been suggested by an
association between a pronounced peritumoral lymphocytic infil-
trate and an improved prognosis (Jass 1986; Halvorsen and Seim,
1989; Di Giorgio et al, 1992). However, the immune defence, if it
was ever raised, appears to have deteriorated at least locally by the
time tumours develop into clinically detectable lesions. This is in
good agreement with the generally found suppression of various
immune activities of tumour-infiltrating mononuclear cells
(MNCs) (Nind et al, 1973; Klein et al, 1980; Bland et al, 1981;
Hutchinson et al, 1981; Vose et al, 1981, 1982; Vose and Moore,
1985; Miescher et al, 1986). Such immunosuppression may be
mediated by tumour-derived factors or subsets ofMNC.
Some cytotoxic activity against malignant cells might, however,
still be present in primary tumours as the degree of mononuclear
cell infiltration has been found to correlate with a favourable prog-
nosis in colorectal cancer (Svennevig et al 1984) and some other
tumours (Haskil, 1982; Hutchinson et al, 1983; Lauder and
Aheme, 1972; Shimokawara et al, 1982; Underwood, 1974;
Werkmeisteret al, 1979). This may indicate that the local immuno-
suppression is reversible (Klein et al, 1980; Hutchinson et al,
1981; Vose and Moore, 1985; Rosenberg et al, 1986).
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An increased numberoflymphocytes was found in colon cancers
compared with normal colons (Svennevig et al, 1982; Allen and
Hogg, 1985). These cells were mainly located to the stroma and not
close to tumour cells (Svennevig et al, 1982; Allen and Hogg,
1985; Koch et al, 1985; Umpleby et al, 1985). Eighty per cent of
the lymphocytes expressed T cell characteristics, 17% B cell char-
acteristics and 6% were null cells (Ebert et al, 1989). The ratio
between helper/inducer cells (CD4+) and cytotoxic/suppressor cells
(CD8+ in colorectal cancers has varied considerably in different
studies (Csiba et al, 1984; Lennard et al, 1984; Allen and Hogg,
1985; Koch et al, 1985; Umpleby et al, 1985; Ebert et al, 1989).
Natural killer cells (NK cells) were either not found or were
present in low numbers (Kornstein et al, 1983; Watanabe et al,
1983; Csiba et al, 1984; Koch et al, 1985; Ebert et al, 1989). This
is compatible with a depressed NK activity of tumour-infiltrating
lymphocytes prepared from colon carcinoma compared with the
activity found in autologous blood T cells from these patients
(Bland et al, 1981; Vose et al, 1981). The number of macrophages
in tumours has varied from sparse (Komstein et al, 1983; Csiba et
al, 1984; Ebert et al, 1989) to frequent (Watanabe et al, 1983;
Allen and Hogg, 1985).
Results from immunohistological studies are thus conflicting,
and information on immunosuppressor and cytotoxic activities of
tumour-infiltrating MNCs in colorectal cancer is almost lacking.
The aim of the present investigation was to use monoclonal
antibodies to identify subsets of tumour-infiltrating mononuclear
cells and study their pattern ofdistribution in relation to regressive
tumour areas and Dukes' class.
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MATERIAL AND METHODS
Patients
This report includes 22 primary colon and four rectal carcinomas
from ten males and 16 females. Median age was 71 years (range
57-84). The number of tumours according to Dukes' classification
was: A 3, B 13, C 5 and D 5. The majority of these tumours
were moderately well differentiated. All Dukes' A, 2/13 Dukes'
B and no Dukes' C tumours were well differentiated and one
poorly differentiated tumour was found in each of Dukes' classes
B, C and D.
Tumour preparation
Surgical specimens were obtained from freshly resected colorectal
carcinomas. The tumour tissue was immediately brought to the
laboratory, cut into I x 1 cm pieces, embedded in OCT compound
(Histo-Lab, Goteborg, Sweden), snap frozen in liquid nitrogen and
stored at -70°C until further processed. Seven out of 26 biopsies
used for immunohistochemical analyses of subsets of tumour-
infiltrating inflammatory cells in this study were obtained at the
advancing border of the tumour.
Monoclonal antibodies
CD4 (Leu-3a, Beckton-Dickinson)
The antigen is present on helper/inducer T subset lymphocytes and
in low density on monocytes and in the cytoplasm of monocytes
and macrophages. Dilution ofthe antibody was 1:25.
CD8 (Leu-2a, Beckton-Dickinson)
The antigen is present on cytotoxic/suppressor lymphocytes. The
antigen is also expressed on some Leu-11+ cytotoxic NK cells, on
a subpopulation of Leu-7+ cells (which do not have cytotoxic and
NK activity), on some Leu-8+ cells (which participate in suppres-
sion ofB cell function) and on Leu-15+ cells, which are associated
with suppressor function. Dilution of the antibody was 1:50.
CD45R (2H4, Coulter, Stockholm, Sweden)
The antigen is expressed on CD4+ and CD8+ T lymphocytes. It is
present on some B and null cells. CD4-positive cells, which
express this antigen, belong to the suppressor/inducer subset.
Dilution ofthe antibody was 1:100.
CD1lb (CR-3, Leu-15 Beckton-Dickinson)
The antigen is present on approximately 30% of peripheral blood
lymphocytes and 90% of NK cells, neutrophils, eosinophils and
monocytes. CD8-positive cells expressing this antigen are associ-
ated with suppression. Dilution ofthe antibody was 1:25.
CDllc (M-5, Beckton-Dickinson)
The antigen is present on monocytes and in low density on granu-
locytes and large granular lymphocytes in peripheral blood. It is
also expressed on macrophages in normal lymphoid tissue and on
Kupffer cells in liver and alveolar macrophages in lung tissue.
Dilution of the antibody was 1:5.
CD25 (IL-2 receptor, Beckton-Dickinson)
The antigen, Tac-antigen or human receptor for interleukin-2
is present on activated T cells, B cells, NK cells and some
macrophages. Dilution ofthe antibody was 1:25.
CD16 (Leu-7, Beckton-Dickinson)
The antigen is present on human NK cells and neutrophils. It is asso-
ciated with the Fc receptor for IgG. The antibody was undiluted.
CD11a (Immunotech, Stockholm, Sweden)
The antigen, alpha-chain of the LFA-1 molecule, is present on
granulocytes and macrophages. Dilution ofthe antibody was 1:100.
MHC I (HLA-ABC, Dakopatts)
The antibody is directed against a monomorphic epitope on the 45-
kDa polypeptide products of the HLA-A, -B and -C loci. Dilution
ofthe antibody was 1:100.
MHC 11 (HLA-DR, Beckton-Dickinson)
The antigen is expressed on B lymphocytes, monocytes/
macrophages, activated T cells and some tumour cells. It is co-
expressed with anti-Leu-6 on Langerhans cells of the epidermis.
Dilution of the antibody was 1:50.
Immunological staining
The biopsies were cut into 6-gm sections and placed on multispot
slides (Novakemi, Stockholm, Sweden) coated with a 0.5% gela-
tine solution. The sections were airdried for 3-18 h before staining
and fixed for 10 min in acetone at 20°C. After drying, the sections
were incubated with monoclonal antibodies (see above) for 30 min.
Mouse IgG (Sigma, Stockholm, Sweden) was used as a negative
control. After washing in phosphate-buffered saline (PBS) twice
for 5 min, the sections were incubated with rabbit anti-mouse
immunoglobulins (Dakopatts), washed and incubated with PAP
mouse (Dakopatts). All dilutions were made in 0.5% PBS-HSA.
All incubation times were 30 min. After washing, the slides were
treated with 0.05% DAB (Sigma, Stockholm, Sweden) in 0.001I%
hydrogen peroxide. Endogenous peroxidase activity was not
blocked before the staining procedure. Human tonsils were used as
a positive control. The slides were counterstained in Mayer's
haematoxylin and mounted in Aquamount (Gurr,Malmo, Sweden).
Evaluation of peritumoral lymphocytic infiltrate
Routine, haemtoxylin and eosin-stained histopathological speci-
mens were used to determine the infiltration oflymphocytes at the
advancing border of the tumours. The degree of the infiltrate was
scored as sparse or moderate/intense.
Evaluation of mononuclear cells
The distribution of infiltrating cells was often heterogeneous, and
counting ofcells per microscopic field was not performed. Instead,
the overall occurrence of each subset of these cells in the intratu-
moral stroma and intermingled between tumour cells was scored
as: - (absent), + (sparse, low numbers), ++ (moderate) and +++
(intense), independently by two investigators having no informa-
tion about the patients or the result of routine histological exami-
nation. Inflammatory cells of necrotic areas were not registered in
this study. There was a more than 90% agreement in the analyses
between the two investigators.
CD4+ mononuclear cells, lymphocytes or macrophages were
identified by their morphological appearance. Cells scored as
lymphocytes had small nuclei and sparse cytoplasm with distinct
cell membrane. In contrast, the macrophages displayed large
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Table 1 Subsets of mononuclear cells showing moderate to intense infiltration into the stroma or between tumour cells
Infiltrating cell type CD Total no. of tumours analysed
Helper lymphocytes
Cytotoxic suppressor lymphocytes
Monocytes
NK cells
Helper/suppressor/lymphocytesa
Suppressor act CD8+ lymphocytesa
LFA1 + cells
IL-2 receptor-positive cells
MHC Il+ infl cells
aSee the text.
CD4
CD8
CD11c
CD16
CD45R
CD11b
CD11a
CD25
26
25
26
24
25
26
24
24
21
No. of tumours with
Tumour infiltration Stromal infiltration
3 18
3 3
3 18
0 2
0 4
2 2
4 16
0 1
2 18
,#~~~~~~~~~~~~~~~~~~~~-
Figure Tumour-infiltrating CD4+ lymphocytes and macrophages (A), CD8+ lymphocytes (B) and CD11c+ macrophages (C). Scale bar =25 gim
~ ~ A b~ii
Figure 2 Areas of tumour destruction invaded by CD4+ (A), CD11c+ (B) and MHC Il+ cells. The majority of inflammatory cells have the morphology of
macrophages. Scale bar = 25 ,um
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nuclei and abundant generally faintly staining cytoplasm and they
were irregularly invading between surrounding structures.
Immunosuppressive activity within the CD8 subset was studied
using MAb to antigen CD1lb. The type of cell, granulocytes,
lymphocytes or macrophages, expressing this complement
receptor was determined by their morphological appearance.
Statistical methods
The difference in distribution of inflammatory cells between
Dukes' stages was analysed using the Fisher's exact test.
RESULTS
Peritumoral lymphocytic infiltrate
In routine histopathological examination, 12 patients had a sparse
lymphocyte infiltration attheadvancing borderofthe tumourand 14
had a moderate to intense infiltrate. All Dukes' A tumours showed a
significant infiltration but seven out of 13 Dukes' B and five out of
ten Dukes' C and D tumours had only a sparse lymphocyte infiltra-
tion. Twelve out of 14 tumours with a moderate to intense lympho-
cyte infiltration at the advancing border also had a moderate to
intense infiltration ofCD4+ cells when subsets ofinflammatory cells
in the intratumoral stroma were analysed. In contrast, in tumours
with only a sparse infiltration at the border, six out of 12 tumours
had a moderate to intense infiltration ofCD4+ cells.
Subsets of tumour-infiltrating mononuclear cells
(MNCs)
Seven outof26 biopsies used for immunohistochemical analyses of
subsets oftumour-infiltrating inflammatory cells in this study were
obtained at the advancing border of the tumour. Five of these
showedonly asparse, and two a moderate,inflammatory reaction at
the border. In this study, only inflammatory cells in the intratumoral
stroma or close to tumour cells were analysed. Thus, the inflamma-
tory response at the advancing edge of the tumours was not
included in the present analyses of subsets of tumour-infiltrating
inflammatory cells and do not influence the results ofthis study.
The number and distribution of various subsets ofMNCs in the
intratumoral stroma and between tumour cells showed consider-
able individual variation. In all tumours except five, lymphocytes
or monocytes were present in fairly large numbers, particularly in
the stroma.
Stromal infiltration of the CD4+ mononuclear cells predomi-
nated over the CD8+ subset (Table 1). Either CD4+ or CD8+ cells
(Figure lA) were present close to tumour cells in fairly high
numbers in four tumours, in two of which both subsets were
present simultaneously. A sparse infiltration of CD4+ and CD8+
cells between tumour cells was present in 16 and four tumours
respectively. Focally large numbers of CD4+ cells were found in
four of these tumours. CD4+ mononuclear cells were either
lymphocytes or macrophages (Figure iB). Out of 26 tumours,
lymphocytes were in the majority in 12 and macrophages in six.
An attempt was made to study the suppressor activity of CD4+
and CD8+ lymphocytes further. Few tumours, however, showed
moderate to intense infiltration of CD45R+ and CDllb+ cells
(Table 1) and with no correlation to Dukes' class. Double staining,
to identify CD4+CD45R+ helper-suppressor cells and CD8+CD
1 b+ suppressor lymphocytes, was therefore not done.
Moderate to intense stromal infiltration ofCD11 c+ macrophages
(Figure IC) was found in all tumours except eight. Significant
infiltration close to tumour cells was found in three and focal infil-
tration in another six tumours. The occurrence of CD11c+ cells
was generally similar to that ofCD4+ cells.
Tumour-infiltrating lymphocytes expressing the interleukin-2
(IL-2) receptor (CD 25) orthe NK cell marker(CD 16) occurred in
low numbers in the stroma, and only scattered cells were found
infiltrating between tumour cells.
Stromal infiltration of CD1Ia+ mononuclear cells was found in
all tumours, but was only sparse in nine ofthem. Significant infil-
tration close to the tumour cells occurred in four tumours.
Expression of major histocompatibility complex (MHC)
I or 11 on tumour cells
MHC I was homogeneously expressed by the malignant cells in all
tumours except three, which contained MHCG I-negative areas.
MHC II was partially expressed by the malignant cells in eleven
tumours, 9/13 Dukes' B and 2/7 Dukes' C. The MHC II-positive
areas ranged from less than 10% to 100% of the tumour cells. All
MHC II-positive tumours, except two (Dukes' C), had an intense
stromal infiltration of CD4+ lymphocytes. Two tumours with the
same infiltration of CD4+ cells did not express MHC II. No corre-
lation was found between any other subset of infiltrating cells and
the expression ofMHC II.
Anti-tumour activity of infiltrating MNCs
Focal areas with regressive changes ofthe tumour were frequently
found in different parts ofthe tumour (Figure 2A, B and C). These
areas were characterized by a deranged histological architecture,
degenerating tumour cells and invasion of inflammatory cells: in
11 tumours by CD4+ cells (Figure 2A), in 15 by CDllc+ cells
(Figure 2B) and in two by CD8+ cells. CD1 b+ cells when present
focally were mainly localized to these destruction areas. The
appearance of these areas of tissue destruction suggests a causal
relation to the cytotoxic activity of infiltrating cells.
Pattern of infiltrating MNCs and tumour stage
according to Dukes' classification
In Dukes' A tumours, the stroma was infiltrated by CD4+ cells, the
vast majority of which were lymphocytes. Cells expressing the
antigen of CD45R or CD1lb, markers for immunosuppressive
activity, in the CD4+ and CD8+ subsets, respectively, were absent
or rare. The infiltration of monocytes/macrophages was sparse to
moderate.
In Duke's B tumours, the stromal infiltration ofCD4+ cells was of
the same magnitude as in Dukes' A (Table 2). However, in Dukes' B
tumours, many ofthese cells hadthe appearance ofmacrophages,but
at least half of them were classified as lymphocytes in all tumours
and lymphocytes were in the majority in 7/13 tumours. CD1Ic+
macrophages were frequently found in all tumours in this stage.
In Dukes' C and D tumours (Table 2), 4/10 tumours showed a
very poor inflammatory reaction. CD4+ cells were predominantly
macrophages in 6/10 of these patients compared with 0/16 in
Dukes' A and B (P=0.002). A moderate to intense infiltration of
CD 1 c+ monocytes/macrophages was found in only a few patients.
In contrast, Dukes' A and B tumours showed large numbers of
these cells (P=0.05).
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Table 2 Mononuclear tumour-infiltrating cells according to Dukes' classes
Dukes' Mononuclear tumour-infiltrating cells
stage
CD4 M0Ly MHC I M0oLy CD11c CD11a
A and B 0/16 5/14 14/16 13/16
C and D 6/10 7/8 4/10 3/9
The number of tumours with moderate to intense infiltration (in stroma and
between tumour cells) of mononuclear cells are shown. MeoLy indicates a
predominance of monocytes / macrophages over lymphocytes.
MHC II+ inflammatory cells were more often predominantly
monocytes/ macrophages in Dukes' C and D than in Dukes' A and
B tumours (P=0.06). This difference in the presence of MHC II+
macrophages correlates to the more frequent appearance of CD4+
macrophages in Dukes' C tumours. Moderate to intense infiltra-
tion ofCD 1 a+ cells was found more frequently in Dukes' A and B
than in Dukes' C and D tumours (P=0.06).
CD 8+ cells and NK cells were rare in all stages. The occurrence
of IL-2 receptor-positive cells was sparse and did not seem to
differ between the various Dukes' stages.
DISCUSSION
The presence of CD4+ and CD8+ tumour-infiltrating lymphocytes
in colorectal cancer has varied in different studies (Csiba et al,
1984; Lennard et al, 1984; Allen and Hogg, 1985; Koch et al,
1985; Umpleby et al, 1985; Ebert et al, 1989). The conflicting
results might to some extent be explained by the complex situation
in these tumours, in which cytotoxic and immunosuppressor activ-
ities are present simultaneously (for further discussion see below).
The predominance ofCD4+ cells as found by us and others can be
caused either by a preferential recruitment of these cells or by
impaired proliferative response and reduced clonogenic potential,
especially oftumour-infiltrating CD8+ cells (Miescher et al, 1988).
In agreement with otherreports, we found thattumour-infiltrating
lymphocytes only occasionally display NK markers (Kornstein etal,
1983; Watanabe et al, 1983; Csiba et al, 1984; Ebert et al, 1989).
This is also compatible with previous data showing a depressed NK
activity of tumour-infiltrating lymphocytes prepared from colon
carcinoma (Bland et al, 1981; Vose et al, 1981).
In this study, an intense infiltration ofCD) lc+ macrophages was
observed in the majority of the tumours. This was also found by
Allen and Hogg 1985), but is contradictory to other studies
(Kornstein et al, 1983; Ebert et al, 1989). Low numbers of
macrophages in some reports on isolated mononuclear cells may
be explained by a loss ofsurface markers or ofmacrophages them-
selves during the preparation procedures. CDllc+ macrophages
were more frequently found in Dukes' B than in Dukes' C and D
tumours and were also present in areas of cytodestruction, indi-
cating a possible cytotoxic activity of these cells. CD4+
macrophages in colorectal cancer were described by Wood et al
(1983) and Umpleby et al (1985). In the present study, this type of
macrophages as found in Dukes' B and predominated over CD4+
lymphocytes in Dukes' C and D tumours.
Lymphocytes expressing the IL-2 receptor have been reported to
increase in colon cancers compared with normal colon tissue and
more in Dukes' C than B tumours (Allen and Hogg, 1985). The
interleukin-2 receptor-positive cells were found in significantly
higher proportions in left-sided than in right-sided tumours, and in
small tumours rather than in large ones (Ebert et al, 1989).
Surprisingly, IL-2 receptor-positive cells were found only rarely in
the tumours analysed in this study.
As shown in this study and by others (Svennevig et al, 1982;
Svennevig et al, 1984; Allen and Hogg, 1985; Koch et al, 1985;
Umpleby et al, 1985), the infiltration of mononuclear cells, as
found in almost all tumours, was generally restricted to the stromal
areas with fairly few cells infiltrating between tumour cells. This
indicates chemotactic activity causing inflammatory cells to leave
the blood vessels, but the migration of inflammatory cells close to
tumourcells is inhibited. A gradient ofimmunosuppressive factors
derived from tumour cells (Remacle-Bonnet et al, 1976;
Whitehead and Kim, 1980; Ebert, 1986; Ebert et al, 1987) or
macrophages or a high concentration of tumour-associated anti-
gens shed into the tissue fluid might down-regulate the migration
and cytotoxic activity of tumour-infiltrating lymphocytes
(Baldwin et al, 1973; Nairn, 1976; Hutchinson et al, 1983). As
previously reported by Svennevig et al (1982), the inflammatory
cell infiltration was low in compact tumour tissue and areas of
extensive necrosis in which the antigen concentration can be antic-
ipated to be particularly high.
Cytotoxic activity against tumourcells in vivo has been reported
(Kornstein et al, 1983) and was also demonstrated in the present
study. In some tumours, focal areas of intense infiltration of
mononuclear cells in close contact with tumour cells were found.
The patchy distribution ofthese areas is compatible with aregional
variation in the immunogenicity of the tumours or variation in the
concentration of chemotactic or blocking factors. Degeneration of
tumours cells was often noticed and the histological architecture of
the tumour tissue was often distorted in these areas. In contrast,
other investigators (Svennevig et al, 1982; Allen and Hogg, 1985)
did not find any sign ofcytotoxic activity against tumour cells. The
pattern of unorganized growth of poorly differentiated tumours
might emerge partly as a result of immunological destruction of
parts of the tumours leaving disorganized clusters of tumour cells,
which are no longer susceptible to destruction by the immune
system. These areas of destruction were generally heavily infil-
trated by macrophages or CD4+ lymphocytes, which might be
cytotoxic (Moretta et al, 1981).
In several studies, no correlation was found between MNC
infiltration (Ebert et al, 1989) and the degree ofdifferentiation ofthe
colorectal carcinomas (Csiba et al, 1984) or class according to
Dukes (Hutchinson et al, 1983; Koch et al, 1985). Svennevig et al
(1984) have suggested that Dukes' stages could be further subclassi-
fied based on infiltrating lymphocyte subpopulations. The frequency
of CD4+ macrophages was found to be increased in more advanced
tumours in our study, which is in agreement with an increased infil-
tration of monocytes, especially in Dukes' C tumours, compared
with normal colon tissue (Allen and Hogg, 1985).
It has been reported that some colorectal carcinomas do not
express MHC I antigens (Csiba et al, 1984; Umpleby et al, 1985;
Momburg et al, 1986; Durrant et al, 1987), which is consistent with
our results. In one study, the expression of MHC I was correlated to
the degree of differentiation of the tumours (Momburg et al, 1986).
The expression ofthe MHC II antigens ofcolorectal carcinoma cells
varied considerably in different studies (Daar et al, 1982; Daar and
Fabre, 1983; Csiba et al 1984; Momburg et al, 1986; Durrant et al,
1987). Poorly differentiated or aneuploid tumours expressed more
of these antigens than well-differentiated or diploid tumours
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(Rognum et al, 1983; Durrant et al, 1987). However, no correlation
between the expression of MHC I or II and the clinicopathological
stage was found by others (Momburg et al, 1986; Durrant et al,
1987). In the present study, most ofthe tumours expressing MHC II
were also heavily infiltrated by CD4+cells,which is compatible with
induction of MHC II expression by interferon-gamma produced by
these cells. A pronounced peri- and intratumoral lymphocytic infil-
trate has repeatedly been shown to be related to a better prognosis
(Jass, 1986; Halvorsen and Seim, 1989; Di Giorgio et al, 1992). Our
results on MHC II expression and appearance ofCD4+ lymphocytes
are, thus, in good agreement with the association between strong
expression ofHLA-DR andgoodprognosis as reported by Andersen
et al (1993). In contrast to our results, Daar et al (1982) did not find
any correlation between the MHC II expression and the degree of
mononuclear cell infiltration.
The function of tumour-infiltrating mononuclear cells can be
interpreted as follows. As the tumours have managed to progress to
clinically detectable lesions, the immune control of these tumours,
ifit was everraised, must have broken down, at least locally. On the
other hand, there is still some cytotoxic activity against the tumour
cells, since specifically cytotoxic cells can be isolated from tumours
and areas ofcytodestruction are observed. Based on present knowl-
edge, a pattern of down-regulation of the immune reactivity in
progressive cancer disease can be suggested. Cytotoxic cells, e.g.
CD8+ lymphocytes and macrophages infiltrate between the tumour
cells in the early phase of the immune
reactivity, as was the case in early oral cancers (Hiratsuka et al,
1984a, b). These cells then disappear gradually, which can explain
the variation in frequency of CD8+ cells in different studies. The
dominating cells in Dukes' A tumours, in the present study, were
CD4+ lymphocytes, while macrophages were sparse. In more
advanced disease, macrophages were more frequent. The dominant
infiltrating CD4+ cells changed from lymphocytes to macrophages,
which comprised less than half of the cells in Dukes' B, but the
majority of CD4+ cells in Dukes' C and D. This might suggest an
immunosuppressor function ofthese macrophages.
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